$GDLG
Glidelogic Corp.

2023 Q4 Form 10-Q Financial Statement

#000109690623002346 Filed on December 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023 Q1
Revenue $0.00 $30.00K $100.7K
YoY Change -100.0% -37.77%
Cost Of Revenue $0.00 $0.00 $80.20K
YoY Change -100.0% -100.0%
Gross Profit $0.00 $30.00K $20.53K
YoY Change -100.0% 170.9%
Gross Profit Margin 100.0% 20.38%
Selling, General & Admin $10.77K $24.15K $24.06K
YoY Change 307.95% 41.98%
% of Gross Profit 80.5% 117.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $110.00 $100.00 $110.00
YoY Change -94.98%
% of Gross Profit 0.33% 0.54%
Operating Expenses -$10.77K $24.15K $24.06K
YoY Change -508.53% 41.96%
Operating Profit -$10.77K $5.850K -$3.530K
YoY Change -812.97% -1.48%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $6.010K
YoY Change
Pretax Income -$10.77K $11.86K -$3.530K
YoY Change 613.25% -299.66%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$10.77K $11.86K -$3.530K
YoY Change 612.97% -299.73%
Net Earnings / Revenue 39.53% -3.5%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 66.59M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.770K $1.760K $14.55K
YoY Change -86.37%
Cash & Equivalents $2.771K $1.760K $14.55K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.771K $1.760K $14.55K
YoY Change -86.37% -91.9% -58.09%
LONG-TERM ASSETS
Property, Plant & Equipment $3.438K $3.540K $3.753K
YoY Change 127.68%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.854K $13.64K $3.753K
YoY Change 355.42% 747.2% 1.57%
TOTAL ASSETS
Total Short-Term Assets $2.771K $1.760K $14.55K
Total Long-Term Assets $6.854K $13.64K $3.753K
Total Assets $9.625K $15.40K $18.30K
YoY Change -55.91% -34.02% -52.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $0.00
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $5.000K $0.00 $6.010K
YoY Change -16.81%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.000K $0.00 $6.010K
YoY Change -16.81% -100.0% -47.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.000K $0.00 $6.010K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $5.000K $0.00 $6.010K
YoY Change -16.81% -100.0% -47.78%
SHAREHOLDERS EQUITY
Retained Earnings $16.26K
YoY Change -1084.26%
Common Stock $66.59K $2.664K
YoY Change 2399.77% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.625K $15.40K $12.29K
YoY Change
Total Liabilities & Shareholders Equity $9.625K $15.40K $18.30K
YoY Change -55.91% -34.02% -52.35%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023 Q1
OPERATING ACTIVITIES
Net Income -$10.77K $11.86K -$3.530K
YoY Change 612.97% -299.73%
Depreciation, Depletion And Amortization $110.00 $100.00 $110.00
YoY Change -94.98%
Cash From Operating Activities $1.010K -$4.140K -$3.420K
YoY Change -107.02%
INVESTING ACTIVITIES
Capital Expenditures $2.350K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 -$2.350K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 1.010K -4.140K -3.420K
Cash From Investing Activities 0.000 0.000 -2.350K
Cash From Financing Activities 0.000 0.000
Net Change In Cash 1.010K -4.140K -5.770K
YoY Change -107.02%
FREE CASH FLOW
Cash From Operating Activities $1.010K -$4.140K -$3.420K
Capital Expenditures $2.350K
Free Cash Flow -$5.770K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-10-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-254750
dei Entity Registrant Name
EntityRegistrantName
GLIDELOGIC CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1575837
dei Entity Address Address Line1
EntityAddressAddressLine1
11264 Playa Court
dei Entity Address City Or Town
EntityAddressCityOrTown
Culver City
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90230
dei City Area Code
CityAreaCode
310
dei Local Phone Number
LocalPhoneNumber
397-2300
dei Phone Fax Number Description
PhoneFaxNumberDescription
Address and telephone number of principal executive offices
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
66593750 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2771 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14547 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2771 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
14547 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3416 usd
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
0 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
3416 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3438 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3753 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
3438 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
3753 usd
CY2023Q4 us-gaap Assets
Assets
9625 usd
CY2023Q1 us-gaap Assets
Assets
18300 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
0 usd
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
6010 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
5000 usd
CY2023Q1 us-gaap Loans Payable
LoansPayable
0 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6010 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
6010 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66593750 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66593750 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66593750 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66593750 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
66594 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
66594 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
-61969 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
-54304 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4625 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
12290 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9625 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18300 usd
CY2023Q4 us-gaap Revenues
Revenues
0 usd
CY2022Q4 us-gaap Revenues
Revenues
94126 usd
us-gaap Revenues
Revenues
30000 usd
us-gaap Revenues
Revenues
142334 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
93000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
130134 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
1126 usd
us-gaap Gross Profit
GrossProfit
30000 usd
us-gaap Gross Profit
GrossProfit
12200 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10773 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2637 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43675 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23279 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
-10773 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
-2637 usd
us-gaap Operating Expenses
OperatingExpenses
-43675 usd
us-gaap Operating Expenses
OperatingExpenses
-23279 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-10773 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1511 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-13675 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11079 usd
CY2023Q4 us-gaap Other Income
OtherIncome
0 usd
CY2022Q4 us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
6010 usd
us-gaap Other Income
OtherIncome
0 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-10773 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-1511 usd
us-gaap Net Income Loss
NetIncomeLoss
-7665 usd
us-gaap Net Income Loss
NetIncomeLoss
-11079 usd
CY2023Q4 fil Net Loss Basic And Diluted
NetLossBasicAndDiluted
0
CY2022Q4 fil Net Loss Basic And Diluted
NetLossBasicAndDiluted
0
fil Net Loss Basic And Diluted
NetLossBasicAndDiluted
0
fil Net Loss Basic And Diluted
NetLossBasicAndDiluted
0
CY2023Q4 fil Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
66593750 shares
CY2022Q4 fil Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
66593750 shares
fil Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
66593750 shares
fil Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
66593750 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
17330 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-1511 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15819 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
15398 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-10773 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4625 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
26898 usd
us-gaap Net Income Loss
NetIncomeLoss
-11079 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15819 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
12290 usd
us-gaap Net Income Loss
NetIncomeLoss
-7665 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4625 usd
us-gaap Net Income Loss
NetIncomeLoss
-7665 usd
us-gaap Net Income Loss
NetIncomeLoss
-11079 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5500 usd
us-gaap Depreciation
Depreciation
315 usd
us-gaap Depreciation
Depreciation
2190 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3416 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
-6010 usd
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
0 usd
fil Increase Decrease In Loan Payable To Parent Company
IncreaseDecreaseInLoanPayableToParentCompany
5000 usd
fil Increase Decrease In Loan Payable To Parent Company
IncreaseDecreaseInLoanPayableToParentCompany
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11776 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14389 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-11776 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-14389 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14547 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34713 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2771 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20324 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Revenues
Revenues
30000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"><b>Use of Estimates</b></p> <p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"> </p> <p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Due to the limited level of operations, the Company has not had to make material assumptions or estimates other than the assumption that the Company is a going concern.</p>
CY2023Q4 fil Nonmonetary Exchange Invoice Amount
NonmonetaryExchangeInvoiceAmount
30000 usd
CY2023Q4 us-gaap Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
4372 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3416 usd
CY2023Q4 fil Nonmonetary Exchange Invoice Amount
NonmonetaryExchangeInvoiceAmount
30000 usd
CY2023Q4 fil Sli Loan Payable Payoff
SliLoanPayablePayoff
-26584 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3416 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8953 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8953 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5200 usd
us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
-315 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5515 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3438 usd
CY2023Q4 fil Loan Waived
LoanWaived
6010 usd
CY2023Q4 fil Sli Loan Payable Payoff
SliLoanPayablePayoff
-26584 usd
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1113 usd
CY2023Q4 fil Sli Loan Payable Payoff
SliLoanPayablePayoff
-26584 usd
CY2023Q4 fil Paid By A Portion Of The Nonmonetary Exchange Invoice Amount From Ar
PaidByAPortionOfTheNonmonetaryExchangeInvoiceAmountFromAR
-26584 usd
CY2023Q4 fil Sli Loan Payable Payoff Net
SliLoanPayablePayoffNet
0 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
5000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2000 usd
CY2021Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3218750 shares
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5150 usd
CY2021Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
9468750 shares
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15150 usd
CY2021Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3906250 shares
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6250 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66593750 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66593750 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66593750 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66593750 shares
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
20817 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
20817 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16260 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20817 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16260 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1113 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3259 usd
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1113 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-3259 usd
us-gaap Other Income Tax Expense Benefit Continuing Operations
OtherIncomeTaxExpenseBenefitContinuingOperations
0 usd
CY2023 us-gaap Other Income Tax Expense Benefit Continuing Operations
OtherIncomeTaxExpenseBenefitContinuingOperations
0 usd

Files In Submission

Name View Source Status
gdlg-20231031_def.xml Edgar Link unprocessable
0001096906-23-002346-index-headers.html Edgar Link pending
0001096906-23-002346-index.html Edgar Link pending
0001096906-23-002346.txt Edgar Link pending
0001096906-23-002346-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gdlg-20231031.htm Edgar Link pending
gdlg-20231031.xsd Edgar Link pending
gdlg-20231031_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
gdlg_ex31z1.htm Edgar Link pending
gdlg_ex31z2.htm Edgar Link pending
gdlg_ex32z1.htm Edgar Link pending
gdlg_ex32z2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
gdlg-20231031_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
gdlg-20231031_pre.xml Edgar Link unprocessable
gdlg-20231031_lab.xml Edgar Link unprocessable